Previous studies have suggested a role for cystic fibrosis transmembrane conductance regulator (CFTR) in the regulation of intracellular vesicular trafficking. A quantitative fluorescence method was used to test the hypothesis that CFTR expression and activation affects endosomeendosome fusion in intact cells. Endosomes from CFTRexpressing and control (vector-transfected) Swiss 3T3 fibroblasts were labeled by internalization with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene (Bodipy)-avidin, a fluid-phase marker whose fluorescence increases -8-fold upon biotin binding. Cells were washed, chased, and then labeled with biotin-albumin or biotin-transferrin. The fraction of Bodipy-avidin-labeled endosomes that fused with bi- The purpose of this study was to investigate whether CFTR expression and activation affects a key cellular process associated with vesicular trafficking-endosome fusion. Endosome-endosome fusion was compared in stably transfected 3T3 fibroblasts (vector control vs. CFTR expressing). This system was chosen because a large body of information was already available on endocytosis, including data that CFTR is expressed and functional at the plasma membrane and in endosomes (16). In addition, these transfected cells permitted direct comparison of cells not expressing CFTR with those expressing relatively high levels of CFTR. Endosome fusion was measured in vivo using a quantitative ratio imaging assay based on an -8-fold increase in 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene (Bodipy)-avidin f luorescence upon binding of biotinylated substrates (26). The fluorescence increase is very fast, irreversible, and pH independent. Endosomes were labeled by internalization in intact cells with Bodipy-avidin and a reference indicator (rhodamine B), chased for specified times with marker-free medium, and then labeled with biotin-albumin or transferrin. Fusion between Bodipy-avidin-and biotin-labeled endosomes was quantified Abbreviations: CF, cystic fibrosis; CFTR, CF transmembrane conductance regulator; Bodipy, 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene; TMR, tetramethylrhodamine; Tf, transferrin; HRP, horseradish peroxidase; Cl2Cf, 5(and 6)-carboxy-2',6'-dichlorocarboxyfluorescein; B/R, Bodipy-to-rhodamine B.
positive diffusion potential generated by the electrogenic proton pump. However, subsequent studies showed no effects of CFTR expression and activation on acidification of the endosomal (15-17) or trans-Golgi (18) compartments.
Bradbury et al. (19) reported that cAMP stimulation by forskolin decreased the rate of endocytosis and increased exocytosis in epithelial cells that express wild-type CFTR, but not in cells expressing the most common mutant AF508 CFTR. They proposed that CFTR may be a general regulator of vesicular trafficking and that the pleiotropic nature of the defects found in CF might be due to abnormal vesicular trafficking in CF cells. Similar effects of CFTR on the rates of exocytosis and/or endocytosis were found in CFTR-expressing vs. CF epithelial cell lines (20-22); however, in other studies, stimulation of cAMP increased exocytosis in both CFTRexpressing and CF pancreatic cells (17) or had no effect on the rate of exocytosis (23). Prince et al. (21) identified CFTR in a rapidly recycling endocytic compartment in T84 cells and found that -50% of cell-surface CFTR was internalized within minutes, a rate much faster than that for other apical membrane glycoproteins. Subsequent studies indicated that CFTR is present (24, 25) and functional (15, 16) in endosomes of CFTR-expressing cells. Although several of the cited studies report apparently conflicting results, they together provide provocative evidence for a role of CFTR in vesicular trafficking.
The purpose of this study was to investigate whether CFTR expression and activation affects a key cellular process associated with vesicular trafficking-endosome fusion. Endosome-endosome fusion was compared in stably transfected 3T3 fibroblasts (vector control vs. CFTR expressing). This system was chosen because a large body of information was already available on endocytosis, including data that CFTR is expressed and functional at the plasma membrane and in endosomes (16) . In addition, these transfected cells permitted direct comparison of cells not expressing CFTR with those expressing relatively high levels of CFTR. Endosome fusion was measured in vivo using a quantitative ratio imaging assay based on an -8-fold increase in 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene (Bodipy)-avidin f luorescence upon binding of biotinylated substrates (26) . The fluorescence increase is very fast, irreversible, and pH independent. Endosomes were labeled by internalization in intact cells with Bodipy-avidin and a reference indicator (rhodamine B), chased for specified times with marker-free medium, and then labeled with biotin-albumin or transferrin. Fusion between Bodipy-avidin-and biotin-labeled endosomes was quantified by ratio-imaging fluorescence microscopy. A significant increase in endosome fusion efficiency was observed only in CFTR-expressing cells after cAMP stimulation. The increase in endosome fusion was not related to rates of endocytic uptake or to endosomal acidification, but required chloride. The results provide evidence for a novel intracellular role for CFTR in endosome-endosome fusion and thus a possible basis for the cellular defects associated with CF.
MATERIALS AND METHODS
Reagents. Bodipy-avidin, biotinamido caproate-N-hydroxy succinimidyl ester, rhodamine B-dextran (Mr, 40,000), 4,4-dif luoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid succinimidylester (Bodipy FL C3-SE) and tetramethylrhodamine-transferrin (TMR-Tf) were purchased from Molecular Probes. Neutravidin was obtained from Pierce. Defatted bovine serum albumin (BSA), horseradish peroxidase (HRP, type II), human transferrin, biotinylated human transferrin, forskolin, and 1,9-dideoxyforskolin were purchased from Sigma. 3-(6-Methoxyquinolino)propanesulfonate (SPQ), biotinylated BSA, and 5(and 6)-carboxy-2',6'-dichlorofluorescein-5(and 6)-carboxytetramethylrhodaminedextran (Mr, 40,000; Cl2Cf-TMR-dextran) were synthesized as described (26, 27) . Bodipy-neutravidin was prepared by reaction of 7 mg of neutravidin with 230 ,ug of Bodipy FL C3-SE in 4 ml of bicarbonate buffer (100 mM) for 1 h. The product was dialyzed against water and lyophilized.
Cell Culture. Control (vector transfected) and stably transfected Swiss 3T3 fibroblasts expressing CFTR were provided by Michael Welsh (University of Iowa). Phenotype analysis was performed by the SPQ assay (16). Only CFTR-expressing cells showed forskolin-stimulated plasma membrane Cl-conductance. Cells were cultured at 37?C in 95% air/5% CO2 in DME-21 medium supplemented with 10% heat inactivated fetal bovine serum (20 min at 56?C) and 1% penicillinstreptomycin. Cells were grown on autoclaved 18-mm diameter round glass coverslips and used when nearly confluent at 12-16 h after plating. For assay of HRP and TMR-Tf uptake, cells were grown in polystyrene 12-well tissue culture plates and used when nearly confluent.
Endosome Fusion Assay. Coverslips were washed twice in internalization medium (IM; 40 mM Na2CO3/70 mM NaCl/5 mM KCl/10 mM Hepes/10 mM D-glucose, pH 7.4), incubated with IM containing Bodipy-avidin (1 mg/ml) plus rhodamine B-dextran (1 mg/ml) at 37?C for 10 min, and then washed twice in IM. After a specified chase time in nonfluorescent serumfree, phenol red-free DME H21 at 37?C, cells were labeled with biotin-transferrin (180 ,ug/ml) or biotin-BSA (16 mg/ml) for 10 min at 37?C. After labeling, cells were washed briefly and perfused with IM at 15?C in a 200-,ul perfusion chamber (16) . Some experiments were performed in Cl--free buffer (135 mM sodium isethionate/3 mM potassium isethionate/1 mM magnesium acetate/i mM calcium acetate/1.5 mM KH2PO4/8 mM Na2HPO4/5 mM glucose) after 1 h incubation in Cl--free buffer using Bodipy-neutravidin (1 mg/ml) instead of Bodipy-avidin. In some experiments forskolin (50 ,uM) was present throughout the labeling period.
Fluorescence Microscopy. The perfusion chamber was positioned on the stage of a noninverted epifluorescence microscope. Cells were illuminated by a stabilized Hg-Xe arc lamp using standard fluorescein isothiocyanate (for Bodipy) and rhodamine (for rhodamine B) filter sets. Fluorescence was collected by a 60X oil immersion objective (Nikon Plan Apo, numerical aperture 1.4) and imaged by a 14-bit, 512 x 512 pixel, cooled CCD camera (AT200 series, Photometrics, Tucson, AZ) containing a high-sensitivity back-thinned detector (TK512CB, Tektronix). In a typical experiment, an image of endosomes was focused manually using the rhodamine filter set. A rhodamine image was acquired over 1 s, the rhodamine filter set was exchanged for the fluorescein isothiocyanate filter set (-2 s), and a Bodipy image was acquired over 2 s. Less than 2% photobleaching occurred under these conditions. Image Analysis. Quantitative ratio imaging of Bodipy-torhodamine fluorescence in individual endosomes was carried out using customized image processing software (27) . Welldemarcated, fluorescently labeled endosomes were identified in the rhodamine image; endosome area, generally 12-30 pixels, was defined based on an algorithm using maximum pixel intensity at the centroid of the endosome and background pixel intensity. Area-integrated pixel intensities of individual endosomes were then computed using as local background the median intensity in a single pixel layer surrounding each endosome. The same set of endosome areas (centers repositioned, if necessary) were used to compute area-integrated pixel intensities in the Bodipy image. After area-integration and background subtraction, Bodipy-to-rhodamine B intensity ratios (B/R) were computed for each endosome. Data were displayed as histograms of the number of endosomes vs. B/R ratio histograms. The fraction of avidin-labeled endosomes that fused with biotin-labeled endosomes was determined by linear regression of B/R histograms to a combination of distributions measured for unfused and 100% fused endosomes (26).
Endosome pH Measurements. The pH of individual fluorescently labeled endosomes was measured by quantitative ratio imaging as described above (27) . Endosomes were pulselabeled by a 10-min incubation with 5 mg/ml Cl2Cf-TMRdextran in IM at 37?C, and then maintained at 37?C for 15 min. Image pairs were acquired using fluorescein and rhodamine filter sets. At the end of each experiment, cells were perfused with high K+ buffers containing 5 ,uM of nigericin titrated to pH 4 and pH 7.5. The Cl2Cf/TMR fluorescence ratio was computed in individual endosomes as described above, and endosome pH was determined from the Cl2Cf/TMR ratio using an in vivo calibration curve (27) Fig. 1B) vs. 10 min  chase time (Fig. 1C) . There was no significant difference in endosome fusion in unstimulated control (solid bars) and CFTR-expressing (open bars) fibroblasts as shown by the near identical histograms (Fig. 1 B Left and C Left) [ffusion = 0.54 and 0.58 (no chase), 0.26 and 0.25 (10 min chase)]; (see Table  1 ). However, in forskolin-stimulated cells, there was a significant increase in endosome fusion in the CFTR-expressing cells [ffusi01 = 0.69 (no chase) and 0.53 (10 min chase)], which is seen by the right shift of the histogram to higher B/R ratios (Fig. 1 B Right and C Right) . The increase in fusion was very pronounced in cells chased for 10 min between the avidin and biotin-albumin pulses (Fig. 1C Right) .
To test whether the forskolin effect was due to a stimulation of intracellular cAMP, a forskolin analog, which does not stimulate cAMP (1,9-dideoxyforskolin; ref. 29) was tested. There was no significant difference in endosome fusion in CFTR-expressing cells without vs. with the addition of dideoxyforskolin (Table 1) .
To determine whether CFTR expression and activation also increased endosome fusion in the receptor-mediated pathway, experiments were carried out in which the fluid phase marker biotin-albumin was replaced by biotin-transferrin, a marker of the early/recycling endosomal compartment. There was no significant difference in endosome fusion in unstimulated cells (Fig. ID Left) . Forskolin addition caused inhibition of endosome fusion in both control and CFTR-expressing cells, but resulted in a net increase in ffu,ion in CFTR-expressing cells (Fig. ID Right) Fig. 2 shows that expression and stimulation of CFTR had no significant effect on the endocytic uptake of HRP or TMR-Tf. These results indicate that the rate of endocytosis cannot account for the increase in endosome fusion.
Maturation of endosomes was assessed from the appearance of f luorescently labeled endosomes at various incubation times and by measurement of endosomal acidification. Fig. 3 shows representative photomicrographs of endosomes from unstimulated and forskolin-stimulated CFTR-expressing fibroblasts at 10 and 30 min after labeling with rhodamine B-dextran. There was no apparent difference in endosome appearance with forskolin, nor was there a difference in endosomes from control vs. CFTR-expressing cells (not shown). Endosome pH was measured by pulse-labeling with the pH-sensitive fluorophore Cl2Cf-TMR-dextran for 10 mmn, followed by incubation The value of ffusion was computed from the B/R distribution by linear regression analysis of data from n endosomes. Experiments were performed with specified chase times at 37?C. Where indicated, forskolin (50 ,uM) or dideoxyforskolin (50 ,LM) was present throughout the experiment. *, P < 0.01 compared to control cells and unstimulated CFTR-expressing cells (unpaired t test). * P < 0.01 compared to forskolin stimulated control cells (unpaired t test). ***, P < 0.01 compared to unstimulated CFTR-expressing cells (unpaired t test). Fig. 5A, Table 1 ). Endocytosis in Cl--depleted cells was comparable to that in the Cl--containing buffer. However, there was no significant effect of forskolin stimulation on the rate of endosome fusion (Fig. 5B, Table 1 ), suggesting that the increased endosome fusion in forskolinstimulated CFTR-expressing cells is related to the Cl--transporting function of CFTR. 15-17, 25) , and CFTR processing and degradation (30, 31). We feel that although further studies of regulation of endosome fusion by CFTR are needed in native epithelia, the novel observation that CFTR activation can increase endosome fusion is independent of cell type.
The principal observation was that CFTR expression and activation was associated with a significant increase in endosome-endosome fusion. Increased fusion was found with either a fluid-phase marker or a receptor-bound ligand (transferrin), which was localized to early/recycling endosomes. The stimulation of fusion was not caused by increased net endocytic uptake or by altered endosomal acidification, but was abolished when cellular chloride was replaced by the relatively impermeant anion isethionate. Therefore, the stimulation of endosome fusion is probably related to the Cl--transporting function of CFTR. Interestingly, Prince et al. 
